Evidence map›Paper›PMID 37345572›Full record

ArticleEpilepsia open2023

Dynamics of glucose concentration during the initiation of ketogenic diet treatment in children with refractory epilepsy: Results of continuous glucose monitoring.

Klára Brožová, Juraj Michalec, Marek Brabec, Petra Bořilová, Pavel Kohout, Jan Brož

Open access · goldAbstract read
In one paragraph

Article in Epilepsia open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Klára BrožováDepartment of Pediatric Neurology, Thomayer University Hospital, Prague, Czech Republic.ORCID 0000-0003-4958-5858
Juraj MichalecDepartment of Internal Medicine, Second Faculty of Medicine, Charles University, Prague, Czech Republic.ORCID 0009-0006-5484-3742
Marek BrabecInstitute of Computer Science, Academy of Science of the Czech Republic, Prague, Czech Republic.ORCID 0000-0001-6367-5791
Petra BořilováDepartment of Pediatric Neurology, Thomayer University Hospital, Prague, Czech Republic.ORCID 0000-0003-2371-3858
Pavel KohoutDepartment of Internal Medicine, Third Faculty of Medicine Charles University and Thomayer University Hospital, Prague, Czech Republic.ORCID 0000-0002-3957-7005
Jan BrožDepartment of Internal Medicine, Second Faculty of Medicine, Charles University, Prague, Czech Republic.ORCID 0000-0003-2465-7333
Charles University · CZCzech Academy of Sciences, Institute of Computer Science · CZThomayer University Hospital · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe ketogenic diet (KD) is a diet low in carbohydrates and rich in fats which has long been used to treat refractory epilepsy. The metabolic changes related to the KD may increase the risk of hypoglycemia, especially during the first days. The study focused on the impact of KD initiation on glycemia in non-diabetic patients with refractory epilepsy.

methodsThe subjects were 10 pediatric patients (6 boys, mean age 6.1 ± 2.4 years), treated for intractable epilepsy. Blinded continuous glucose monitoring system (CGM) Dexcom G4 was used. Patients started on their regular diet in the first 36 hours of monitoring, followed by an increase in lipids intake and a gradual reduction of carbohydrates (relations 1:1; 2:1; 3:1; 3.5:1). We analyzed changes in glycemia during fat: nonfat ratio changes using a generalized linear model.

resultsThe mean monitored time per person was 6 days, 10 hours and 44 minutes. The mean ± SD glycemia for the regular diet was 4.84 ± 0.20 mmol/L, for the carbohydrates/fat ratio of 1:1 it was 4.03 ± 0.16, for the ratio of 2:1 it was 3.57 ± 0.10, for the ratio 3:1 it was 3.39 ± 0.13 and for the final ratio of 3.5:1 it was 2.79 ± 0.06 mmol/L (P < 0.001). The portions of time spent in glycemia ≤3.5 mmol/L (≤2.5 mmol/L respectively) were: on the normal diet 0.88% (0.31%) of the monitored period, during 1:1 KD ratio 1.92% (0.95%), during 2:1 ratio 3.18% (1.02%), and during 3:1 and 3.5:1 ratios 13.64% (2.36%) of the monitored time (P < 0.05). SIGNIFICANCE: Continuous glucose monitoring system shows the dynamic of glucose concentration in ketogenic diet treatment initiation. It may be a useful tool to control the effects of this diet on glucose metabolism, especially in hypoglycemia detection.

Indexed as

Diet, KetogenicDrug Resistant EpilepsyHypoglycemiaBlood GlucoseBlood Glucose Self-MonitoringChildChild, PreschoolDietary FatsHumansMaleProspective StudiesBlood GlucoseDietary Fatscensored datacontinuous glucose monitoringepilepsyglucose concentrationketogenic diet

Identifiers

PMID37345572
PMCPMC10472364
OpenAlexW4381597891

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.